Hypertension and Nephrology

Loading the player...

Results of ISCHEMIA-CKD with Dr. Sripal Bangalore

Sripal Bangalore, MD explains the results of the ISCHEMIA-CKD trial, in which researchers compared invasive versus conservative treatment strategies for patients with at least moderate ischemia and advanced chronic kidney disease. Dr. Bangalore is the director of research at the cardiac catheterization lab at NYU Langone Health. See this study and other late-breaking science presentations on our AHA Science News page.

Science NewsView All Science News

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with und...
AHA Journals This Week | July 6, 2020
07/06/2020 | AHA Journals This Week July 6, 2020

2017 Hypertension Clinical Guidelines

  • This guideline is an update of the National Heart, Lung, and Blood Institute publication, “The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure” (JNC 7) and is a comprehensive resource for the clinical and public health practice communities.
  • Previous guidelines identified high blood pressure as ≥ 140/90 mm Hg. This guideline now defines high blood pressure to be anyone with a systolic blood pressure (SBP) ≥ 130 mm Hg or diastolic blood pressure (DBP) ≥ 80 mm Hg.
  • The change will mean more patients are diagnosed with hypertension. To improve blood pressure control and reduce cardiovascular disease (CVD) risk in these patients, a small percentage of them will be asked to take medications while the majority will be recommended for nonpharmacological interventions with healthy lifestyle changes.

See the full Science News coverage for the 2017 Hypertension Clinical Guidelines

Impact Your Practice with Scientific Sessions OnDemand(tm) Hypertension and Nephrology Track Available Now!

Related Meetings


September 10–13, 2020
New Orleans, La.

American Heart Association | Scientific Sessions

Nov. 14–16, 2020
Dallas, Texas

International Stroke Conference

February 10–12, 2021
Denver, Colo.

Related Councils

Council on Hypertension

Karen A. Griffin, MD, FAHA, FASH, FASN, FACP

The mission of the Council on Hypertension is "to foster excellence in hypertension research and education" in order to achieve the American Heart Association?s goal ?to be a relentless force for a world of longer, healthier lives." Hypertension remains a world-wide public-health challenge and is a leading cause of stroke, heart disease, and the progression of chronic kidney disease.

Karen A. Griffin, MD, FAHA, FASH, FASN, FACP
Chair, Council on Hypertension

Hypertension Scientific Sessions       Hypertension       Hypertension Council Awards

Council on the Kidney in Cardiovascular Disease (KCVD)

Alexander Staruschenko, PhD, FAHA

The American Heart Association (AHA) Council on the Kidney in Cardiovascular Disease (KCVD) mission is to reduce cardiovascular-related disability and death through research, communication, advocacy and education about the kidney.

Kidney disease is a major cause and a consequence of cardiovascular disease. Chronic renal insufficiency is thought to be an independent risk factor for developing hypertension, vascular disease, atherosclerosis and other morbidity and mortality risk factors. Patients with cardiovascular disease and diabetes are also at high risk for developing kidney failure.

Alexander Staruschenko, PhD, FAHA
Chair, Council on the Kidney in Cardiovascular Disease

Hypertension Scientific Sessions       Hypertension       KCVD Council Awards